Journal
BLOOD PRESSURE
Volume 31, Issue 1, Pages 228-235Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/08037051.2022.2118662
Keywords
Blood pressure variability; blood pressure time in therapeutic range; cardiovascular risk; hypertension; primary prevention; prognosis
Categories
Ask authors/readers for more resources
This study investigated the association between blood pressure control measures, visit-to-visit blood pressure variability, and time in therapeutic range (TTR) with future cardiovascular outcomes in hypertensive patients. The results showed that high blood pressure variability and low TTR were associated with increased risk of cardiovascular events, and the significance of TTR appeared to be greater than blood pressure variability in predicting outcomes.
Purpose We investigated whether blood pressure (BP) control measures, visit-to-visit BP variability, and time in therapeutic range (TTR) are associated with future cardiovascular outcomes in hypertensive patients. Materials and Methods Among 1,408 hypertensive patients without cardiovascular disease, we prospectively evaluated the incident major cardiovascular events over 6 years. In newly diagnosed patients, antihypertensive drug treatment was initiated. We estimated two markers of on-treatment BP control, (1) visit-to-visit BPV as the coefficient of variation of office systolic BP (BP-CV), and (2) TTR calculated as the percentage of office systolic BP measurements within 120-140mmHg across visits. Results The hypertensive cohort (672 males, mean age 60 years, 31% newly diagnosed) had a mean systolic/diastolic BP of 142/87 mmHg. The mean number of visits was 4.9 +/- 2.6, while the mean attained systolic/diastolic BP during follow-up was 137/79 mmHg using 2.7 +/- 1.1 antihypertensive drugs. The BP-CV and TTR were 9.1 +/- 4.1% and 45 +/- 29%, respectively, and the incidence of the composite outcome was 8.3% (n = 117). After adjustment for relevant confounders and standardization to z-scores, BP-CV and TTR were associated with a 43% (95% CI, 27-62%) increase and a 33% (95% CI, 15-47%) reduction in the outcome. However, the joint evaluation of TTR and BP-CV in a common multivariable model indicated that a standardized change of TTR was associated with the outcome to a greater extent than BP-CV (mean hazard ratios of 30% vs. 24%, respectively). When combined with the higher BP standardized-CV quartile, the lower TTR quartile predicted the outcome by 2.3 times (95% CI, 1.1-5.4) compared to the inverse TTR and BP-CV quartile pattern. Conclusion High BP-CV or low TTR was associated with future cardiovascular events in a cohort of treated hypertensive patients. As a determinant, the extent of TTR value appears greater than BP-CV when these measures are considered in the same multivariable model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available